134 results on '"Menarguez, Javier"'
Search Results
2. Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
3. Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma
4. Composite Lymphoma Containing Mantle Cell and Peripheral T-cell Lymphoma, Not Otherwise Specified: A Report of 2 Cases Treated With Up-front Autologous Stem Cell Transplantation
5. Cell-Free DNA dynamic concentration and other variables are predictors of early progression after CAR T-Cell therapy in DLBCL patients.
6. Genetic and phenotypic characterisation of HIV ‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
7. Evaluación sistemática de la biopsia de médula ósea en casos de sospecha de mielofibrosis primaria. Propuesta de informe diagnóstico estandarizado. Consenso de expertos de las SEAP/SEHH
8. Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study
9. Abstract 2502: Unravelling the heterogenous molecular landscape of pediatric post-transplant lymphoproliferative disorders
10. Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results
11. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells
12. Tumour Suppressor Genes in Hodgkin’s Disease
13. Cell-Free DNA Dynamic Concentration, CRP and LDH Pre-Infusion Are Predictors of Early Progression after CAR T-Cell Therapy in DLBCL Patients
14. A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
15. Hemophagocytic Lymphohistiocytosis/Macrophage-Activation Syndrome (HLH/MAS) Following Treatment with Tisagenlecleucel
16. Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma
17. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma
18. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
19. Liquid Biopsy Is Useful to Identify the Genetic Profile of NHL-B at Diagnosis in Different Histological Subtypes
20. Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases
21. Lymphocyte immunophenotype of circulating angioimmunoblastic T-cell lymphoma cells
22. Parathyroidectomy: Whom and when?
23. Chromosomal aberrations, the consequence of refractory hyperparathyroidism: Its relationship with biochemical parameters
24. Comparative study of the expression of proteins involved in the cell cycle in renal secondary hyperparathyroidism
25. Response of parathyroid glands to calcitriol in culture: Is this response mediated by the genetic polymorphisms in vitamin D receptor?
26. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays
27. Composite Lymphoma Containing Mantle Cell and Peripheral T-cell Lymphoma, Not Otherwise Specified: A Report of 2 Cases Treated With Up-front Autologous Stem Cell Transplantation
28. Acellular human heart matrix: A critical step toward whole heart grafts
29. Linfoma angioinmunoblástico en anciana de 73 años
30. Analysis of the Genomic Heterogeneity in Hodgkin Lymphoma Using Next Generation Sequencing
31. PIM Kinases Inhibition, a Rational Strategy in Peripheral T-Cell Lymphomas,
32. PI3K Inhibition As a Potential Therapeutic Strategy in Peripheral T-Cell Lymphomas,
33. Bcl2 Over-Expression as a Prognostic factor In Hodgkin Lymphoma Patients who Required Intensive Treatment
34. MicroRNA Signatures In B-Cell Lymphomas
35. Integrative Analysis of MicroRNA and Gene Expression Profiling Contributes to Understand Mantle Cell Lymphoma Pathogenesis.
36. Identification of Molecular Risk Score in Advanced Hodgkin Lymphoma: Integrating Tumor and Microenvironment Signatures.
37. Essential Thrombocythemia in Patients with Platelet Counts below 600×109/L: Applicability of the 2008 World Health Organization Diagnostic Criteria Proposal
38. Frequency ofBCL2andBCL6translocations in follicular lymphoma: Relation with histological and clinical features
39. An Enriched Multigen Low-Density Array To Predict Outcome in Advanced Hodgkin Lymphoma Paraffin-Embedded Samples.
40. Naso-Maxillary Non-Hodgkin Lymphoma Associated With Methotrexate Treatment in a Patient With Rheumatoid Arthritis
41. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis
42. Lymphoma Associated Chromosomal Abnormalities Can Be Easily Detected by FISH on Tissue Imprints. an Underused Diagnostic Alternative.
43. The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature
44. Epstein-Barr Virus-Latent Membrane Protein 1 Expression Has a Favorable Influence in the Outcome of Patients with Hodgkin's Disease Treated with Chemotherapy
45. Other Cancers in Patients with Gastric Malt Lymphoma
46. Oncogene Expression in Tumour Cells of Pediatric Hodgkin's Disease in Argentina — Correlation with Epstein Barr Virus Presence
47. Bilateral Occipital Lobe Infarction Probably Due to Disseminated Zygomycosis in a Patient with Lymphoma
48. Evaluation of the International Index in the Prognosis of High Grade Gastric Malt Lymphoma
49. Micro RNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
50. Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.